TL/DR –
A new study in the American Journal of Respiratory and Critical Care Medicine suggests that policies in Donald Trump’s second term could drive increased rates of lung disease and premature death. The study scrutinizes actions across ten sectors, including healthcare access, environmental regulation, and workplace safety. The One Big Beautiful Bill Act (OBBBA), which cut over $1tn from health programs, is of particular concern, as it could decrease access to care for many people relying on Medicaid, lower vaccination rates, and reduce access to emergency treatments and medicine.
Trump Policies linked to Rising Lung Disease Rates and Premature Death
A new detailed study by pulmonary specialists and public health experts suggests that Donald Trump’s policies could increase lung disease rates and premature death. As per the analysis published in the American Journal of Respiratory and Critical Care Medicine, such health threats result from policies implemented during Trump’s second term in areas like healthcare access, environmental regulation, workplace protections, and vaccine uptake.
The research indicates that these policies could escalate lung disease incidences, exacerbate existing conditions, and undermine patient care, potentially resulting in millions of needless deaths. White House spokesperson Kush Desai insists that the Trump administration is not jeopardizing healthcare access.
The report highlights immediate concerns related to healthcare cuts in Trump’s second-term tax and spending package, known as the One Big Beautiful Bill Act (OBBBA). These cuts, representing the largest federal healthcare rollbacks in American history, threaten healthcare access for millions, potentially lowering vaccination rates and decreasing medication access.
Over the past year, the Trump administration has rolled back numerous air pollution standards, which could lead to increased asthma and hospitalizations for respiratory illness.
“At every turn, this administration is putting the potential economic gains of polluters ahead of clean air and the respiratory health of Americans,” observed Mary B Rice, director of the Center for Climate, Health and the Global Environment at Harvard.
The paper outlines additional risks, including delayed workplace protections for coal miners, public health funding cuts at the CDC and FDA, and declining vaccine uptake. “Recent federal actions will cost Americans dearly,” warned Liz Scott, a senior director at the American Lung Association.
No population will be entirely protected from lung disease, which affects all socioeconomic levels. However, policy choices will disproportionately impact certain groups, including coal miners and Black communities with higher asthma rates. The study advocates for a return to public health-focused missions at federal agencies and the pursuit of positive health policies.
—
Read More Health & Wellness News ; US News